MR-simulation in Radiotherapy for Prostate Cancer
Research type
Research Study
Full title
An exploratory study to assess the feasibility of incorporating MR in the radiotherapy pathway of patients with prostate cancer
IRAS ID
215681
Contact name
Christopher M Thomas
Contact email
Sponsor organisation
Guy's & St Thomas' Foundation NHS Trust
Duration of Study in the UK
1 years, 6 months, 1 days
Research summary
Conventional radiotherapy treatment planning uses computed tomography (CT) scans to provide an accurate 3-D picture of the local anatomy. This helps the planners to maximise the radiation dose delivered to the prostate, whilst minimising the dose to surrounding normal tissue. Magnetic resonance imaging (MRI) scanning is an established diagnostic imaging technique that provides even clearer images of the local anatomy. However, until recently the technology hasn’t existed to allow us to perform MRI scans with patients “set-up” in the position required to plan and deliver radiotherapy to the prostate. This study is being performed to assess methods that may allow us to incorporate MRI scans into the radiotherapy planning process, which may further increase the accuracy of the treatment, reducing the irradiation of surrounding normal tissue and minimising toxicity.
REC name
London - Fulham Research Ethics Committee
REC reference
17/LO/0104
Date of REC Opinion
20 Jan 2017
REC opinion
Favourable Opinion